MediFind found 7 doctor with experience in RUNX1 Familial Platelet Disorder near Egypt. Of these, 7 are Experienced.
Hossam Hodeib practices in Tanda, Egypt. Mr. Hodeib is rated as an Experienced expert by MediFind in the treatment of RUNX1 Familial Platelet Disorder. His top areas of expertise are RUNX1 Familial Platelet Disorder, Blood Clots, Congenital Heart Disease (CHD), and Polycythemia Vera.
Dina Abdelhai practices in Tanda, Egypt. Ms. Abdelhai is rated as an Experienced expert by MediFind in the treatment of RUNX1 Familial Platelet Disorder. Her top areas of expertise are RUNX1 Familial Platelet Disorder, Secernentea Infections, Non-Alcoholic Fatty Liver Disease, and Trichinosis.
Doaa El Amrousy practices in Tanda, Egypt. Ms. El Amrousy is rated as an Experienced expert by MediFind in the treatment of RUNX1 Familial Platelet Disorder. Her top areas of expertise are Childhood Iron Deficiency Anemia, Congenital Hyperinsulinism, His Bundle Tachycardia, and High Blood Pressure in Infants.
Omneya Omar practices in Alexandria, Egypt. Omar is rated as an Experienced expert by MediFind in the treatment of RUNX1 Familial Platelet Disorder. Their top areas of expertise are 3M Syndrome, Homozygous Familial Hypercholesterolemia (HoFH), Childhood Iron Deficiency Anemia, and Gaucher Disease.
Amira Youssef practices in Tanda, Egypt. Ms. Youssef is rated as an Experienced expert by MediFind in the treatment of RUNX1 Familial Platelet Disorder. Her top areas of expertise are RUNX1 Familial Platelet Disorder and Blood Clots.
Nahed Hablas practices in Tanda, Egypt. Hablas is rated as an Experienced expert by MediFind in the treatment of RUNX1 Familial Platelet Disorder. Their top areas of expertise are Beta Thalassemia, Hemoglobinopathy, Thalassemia, and Congenital Hemolytic Anemia.
Mona Abdellateif practices in Cairo, Egypt. Ms. Abdellateif is rated as an Experienced expert by MediFind in the treatment of RUNX1 Familial Platelet Disorder. Her top areas of expertise are Acute Myeloid Leukemia (AML), Thyroid Nodule, Leukemia, and Acute Lymphoblastic Leukemia (ALL).
Last Updated: 01/09/2026